Biotech stocks are experiencing substantial moves in pre-market activity on Monday, indicating potential trading opportunities.
By evaluating sentiment and momentum before the bell, pre-market analysis becomes a foundational step in any trader's pre-market routine.
In the Green - Pre-market Gainers
On Monday, the following stocks are trading significantly higher in the pre-market session.
1. Fulcrum Therapeutics Inc. (FULC) - up 52% at $13.502. Barinthus Biotherapeutics PLC - ADR. (BRNS) - up 25% at $0.903. Immix Biopharma Inc. (IMMX) - up 20% at $6.654. Arcellx Inc. (ACLX) - up 14% at $79.455. Ocular Therapeutix Inc. (OCUL) - up 13% at $14.206. HeartSciences Inc. (HSCS) - up 12% at $2.977. Kymera Therapeutics Inc. (KYMR) - up 11% at $73.888. Dyne Therapeutics Inc. (DYN) - up 11% at $22.509. Armata Pharmaceuticals Inc. (ARMP) - up 10% at $6.2010. ALX Oncology Holdings Inc. (ALXO) - up 9% at $1.55
In the Red - Premarket Losers
The following stocks are trading lower in the pre-market session on Monday.
1. Polyrizon Ltd. (PLRZ) - down 22% at $10.202. Sensei Biotherapeutics Inc. (SNSE) - down 17% at $8.023. Meihua International Medical Tech Co Ltd. (MHUA) - down 12% at $14.02 4. Basel Medical Group Ltd. (BMGL) - down 9% at $0.965. Pharmacyte Biotech Inc. (PMCB) - down 7% at $1.136. Q32 Bio Inc. (QTTB) - down 2% at $3.27
For comments and feedback contact: editorial@rttnews.com
December 19, 2025 15:10 ET U.S. inflation data and interest rate decisions by major central banks were the highlights of this busy week for economics news flow. Employment data and survey results on the housing markets also gained attention in the U.S. In Europe, the European Central Bank and Bank of England announced their policy decisions and macroeconomic projections.